Dew, to what extent, if any, are you concerned that the FDA might ultimately ask MNTA/NVS to run clinical trials to compare its generic lovenox to the branded version? I imagine the FDA would have requested this long ago if it had concerns that MNTA/NVS' generic lovenox were not comparable to the branded version.